News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2024
August 2024
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Ink Factory captures the essence of KCRS24 in real time – KidneyCAN
Photo from KidneyCAN/X
Jul 14, 2024, 07:15

Ink Factory captures the essence of KCRS24 in real time – KidneyCAN

KidneyCAN shared on X:                                    .

“We’re thrilled to have Ink Factory capturing the essence of KCRS24 in real time! Their stunning visual notes bring our sessions to life, making complex concepts accessible and engaging. Check out some of their incredible work so far!”

Ink Factory captures the essence of KCRS24 in real time - KidneyCAN

Source: KidneyCAN/X

cancer Ink factory KCRS24 KidneyCAN OncoDaily Oncology
Blog
Aug 25, 2024, 20:23
First recommendations from the ESMO/ SIOG about Geriatric Assessment and Personalised Care
Blog
Aug 25, 2024, 20:14
CPOEM Foundation's first support group webinar for patients with multiple myeloma
Blog
Aug 25, 2024, 20:10
Urgent need for new therapies for colorectal cancer patients with MSS disease - Agenus
Blog
Aug 25, 2024, 20:04
Olubukola Ayodele is nominated for a UHL Recognition Award 2024
Blog
Aug 25, 2024, 19:57
Miriam Mutebi: "Can food cure cancer?"
Blog
Aug 25, 2024, 19:47
Paxman Scalp Cooling's Q2 2024 report
Blog
Aug 25, 2024, 19:31
Mark Lawler: Time to defuse the ticking time bomb
Blog
Aug 25, 2024, 19:25
Excellent review of clinical trials involving inhibition of immune checkpoints and Radiotherapy
Dialogues
Aug 25, 2024, 17:20
Beyond The Cancer Diagnosis: Dialogue with Sonia Amin Thomas, Hosted By Adrian Pogacian
Blog
Aug 25, 2024, 17:04
Rahul Gosain: Current SoC/landscape for Follicular and Mantle Cell Lymphoma with Pallawi Torka
Blog
Aug 25, 2024, 16:51
Mark Lewis: A hard-fought remission that ushers in constant fear is a Pyrrhic victory
Blog
Aug 25, 2024, 16:46
Paola Alberti: Neuroprotection against of Molsidomine against vincristine-induced peripheral neurotoxicity